Showing results (521-530 of 556) with videos related to

Sort By:
Pageof 56
Small (Weinheim an Der Bergstrasse, Germany)|August 24, 2023
Reconstituted Extracellular Vesicles from Human Platelets Decrease Viral Myocarditis in MiceDanielle J Beetler, Katelyn A Bruno, Molly M Watkins, et al.
Circulation Research|October 6, 2023
Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac FibrosisDuan Liu, Min Wang, Vishakantha Murthy, et al.
Respiration; International Review of Thoracic Diseases|June 12, 2026
Real-world Sotatercept Eligibility: Analysis from the FOCUS-PAH RegistryGiulio Savonitto, Giovanni Santi, Matteo Pagnesi, et al.
International Journal of Cardiology|August 4, 2026
Prognostic relevance of the right ventricular fractional area change to pulmonary artery systolic pressure ratio in pulmonary arterial hypertension: Insights from the FOCUS-PAH registryPier Paolo Bocchino, Martina Pecoraro, Ilaria Pagliassotto, et al.
Frontiers in Immunology|January 21, 2025
Therapeutic effects of platelet-derived extracellular vesicles on viral myocarditis correlate with biomolecular contentDanielle J Beetler, Presley Giresi, Damian N Di Florio, et al.
Mayo Clinic Proceedings. Digital Health|April 10, 2025
RApid Throughput Screening for Asymptomatic COVID-19 Infection With an Electrocardiogram: A Prospective Observational StudyDemilade Adedinsewo, Jennifer Dugan, Patrick W Johnson, et al.
Cell Communication and Signaling : CCS|November 27, 2025
Donor-dependent heterogeneity in therapeutic effects of adipose tissue extracellular vesiclesDanielle J Beetler, Presley Giresi, Vivian Xu, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 20, 2025
Change in prevalence of ATTR variants in Italy - Results from a National SurveyCarlo Fumagalli, Simone Longhi, Alberto Aimo, et al.
Biology of Sex Differences|December 19, 2024
Sex differences in mitochondrial gene expression during viral myocarditisDamian N Di Florio, Gabriel J Weigel, David J Gorelov, et al.
European Journal of Heart Failure|June 26, 2024
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registryRiccardo M Inciardi, Muthiah Vaduganathan, Carlo M Lombardi, et al.
Pageof 56